Free tool
FAERS Monitor: Plegisol In Plastic Container
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018608 or its brand name (Plegisol In Plastic Container, Calcium Chloride, Magnesium Chloride, Potassium Chloride, Sodium Chloride). Reports on generic versions are filed under their own applications.
Reports
16
Serious
11
69% of reports
Hospitalization
4
Death reported
4
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective5
- cerebrovascular accident3
- renal failure3
- injury2
- multiple sclerosis2
- peripheral vascular disorder2
- renal injury2
- acute kidney injury1
- acute respiratory failure1
- anaemia1
- anaphylactic reaction1
- anxiety1
- aortic valve incompetence1
- asthenia1
- atrial fibrillation1
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1 |
| 2005 | 2 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 1 |
| 2019 | 3 |
| 2022 | 3 |
| 2025 | 1 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,143 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| peripheral vascular disorder | 2 | 510.5 | 139.6 | 571 |
| aortic valve incompetence | 1 | 309.0 | 46.3 | 76 |
| renal injury | 2 | 88.5 | 24.2 | 97 |
| acute respiratory failure | 1 | 68.3 | 10.2 | 16 |
| multiple sclerosis | 2 | 55.0 | 15.0 | 59 |
| injury | 2 | 37.4 | 10.2 | 39 |
| renal failureSignal | 3 | 29.7 | 10.7 | 57 |
| anaphylactic reaction | 1 | 23.8 | 3.6 | 5 |
| cerebrovascular accidentSignal | 3 | 23.3 | 8.4 | 44 |
| atrial fibrillation | 1 | 13.5 | 2.0 | 2 |
| acute kidney injury | 1 | 8.6 | 1.3 | 1 |
| anaemia | 1 | 6.9 | 1.0 | 1 |
| drug ineffectiveSignal | 5 | 5.0 | 2.4 | 13 |
| anxiety | 1 | 4.6 | 0.7 | 0 |
| asthenia | 1 | 3.5 | 0.5 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.